| Recombinant porcine sequence factor VIII (rp FVIII) for acquired haemophilia A: practical clinical experience of its use in seven patients MD Tarantino, A Cuker, B Hardesty, JC Roberts, M Sholzberg Haemophilia 23 (1), 25-32, 2017 | 71 | 2017 |
| Global seroprevalence of pre-existing immunity against AAV5 and other AAV serotypes in people with hemophilia A R Klamroth, G Hayes, T Andreeva, K Gregg, T Suzuki, IH Mitha, ... Human gene therapy 33 (7-8), 432-441, 2022 | 56 | 2022 |
| Plasminogen replacement therapy for the treatment of children and adults with congenital plasminogen deficiency AD Shapiro, C Nakar, JM Parker, GR Albert, JE Moran, K Thibaudeau, ... Blood, The Journal of the American Society of Hematology 131 (12), 1301-1310, 2018 | 40 | 2018 |
| Translating sickle cell guidelines into practice for primary care providers with Project ECHO LM Shook, CB Farrell, KA Kalinyak, SC Nelson, BM Hardesty, ... Medical education online 21 (1), 33616, 2016 | 30 | 2016 |
| Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C→ T mutation A Sharathkumar, B Hardesty, A Greist, J Salter, B Kerlin, M Heiman, ... Haemophilia 15 (1), 91-100, 2009 | 26 | 2009 |
| Thrombin and plasmin generation in patients with plasminogen or plasminogen activator inhibitor type 1 deficiency JL Saes, SEM Schols, KF Molitor, M van Geffen, K Verbeek‐Knobbe, ... Haemophilia 25 (6), 1073-1082, 2019 | 11 | 2019 |
| Factor V east Texas variant causes bleeding in a three‐generation family JA Peterson, S Gupta, ND Martinez, B Hardesty, SA Maroney, AE Mast Journal of Thrombosis and Haemostasis 20 (3), 565-573, 2022 | 9 | 2022 |
| S853 SUCCESSOR: A MULTICENTER RETROSPECTIVE NONINTERVENTIONAL FOLLOW‐UP STUDY IN PATIENTS WITH SICKLE CELL PAIN CRISES WHO PREVIOUSLY PARTICIPATED IN THE SUSTAIN TRIAL IN THE … D Liles, N Shah, B Scullin, V Gordeuk, W Smith, J Kanter, M Achebe, ... HemaSphere 3, 380-381, 2019 | 5 | 2019 |
| Clinical features of children, adolescents, and adults with coexisting hypermobility syndromes and von Willebrand disease SA Hall, ER Meier, S Gupta, C Nakar, A Rampersad, N Bakeer, ... Pediatric Blood & Cancer 65 (12), e27370, 2018 | 5 | 2018 |
| Long‐term biological effects in sickle cell disease: insights from a post‐crizanlizumab study DK Liles, NR Shah, B Scullin, VR Gordeuk, WR Smith, J Kanter, ... British Journal of Haematology 195 (4), e150-e153, 2021 | 4 | 2021 |
| Pro3 successor study: Treatment and health care resource utilization by sickle cell patients who participated in the sustain study in the united states N Shah, R Boccia, WK Kraft, BM Hardesty, J Paulose, D Lainé, ... Value in Health 22, S335, 2019 | 4 | 2019 |
| Primary teratoma of the lesser sac: Lesser sac teratoma BM Hardesty, TM Ulbright, C Touloukian, LH Einhorn Case Reports in Oncological Medicine 2012, 2012 | 4 | 2012 |
| Global seroprevalence of pre‐exisiting immunity against various AAV serotypes the haemophilia A population G Hayes, T Andreeva, K Gregg, R Klamroth, B Hardesty, J Warren, P Slev, ... ISTH Acad, 273858, 2019 | 3 | 2019 |
| Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review AD Shapiro, BM Hardesty, F Peyvandi, A Iorio Research and Practice in Thrombosis and Haemostasis 7 (1), 100007, 2023 | 2 | 2023 |
| Global seroprevalence of pre-existing antibodies against various AAV serotypes in hemophilia A adults and adolescents GM Hayes, T Andrea, R Klamroth, B Hardesty, T Suzuki, N Stieltjes, ... Haemophilia 26, 20-21, 2020 | 2 | 2020 |
| A multicenter retrospective noninterventional follow-up study in patients with sickle cell pain crisis who previously participated in the sustain trial in the United States … N Shah, R Boccia, WK Kraft, BM Hardesty, J Paulose, D Laine, ... Blood 132, 4910, 2018 | 2 | 2018 |
| Using Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest LM Shook, CB Farrell, KA Kalinyak, SC Nelson, BM Hardesty, ... Blood 128 (22), 5923, 2016 | 2 | 2016 |
| Inflammation and autoimmunity are interrelated in patients with sickle cell disease at a steady-state condition: implications for vaso-occlusive crisis, pain, and sensory … W Li, AQ Pucka, C Debats, BA Reyes, F Syed, ARW O’Brien, R Mehta, ... Frontiers in Immunology 15, 1288187, 2024 | 1 | 2024 |
| Increasing Visibility of Sickle Cell Disease in Indiana: Establishing Baseline Prevalence Using Integrated Data From Multiple Sources AI Okolo, SA Jacob, BE Dixon, NR Valvi, IA Janson, BM Hardesty Public Health Reports 139 (2), 201-207, 2024 | | 2024 |
| Real‐world safety and effectiveness of recombinant porcine sequence factor VIII in acquired haemophilia A: A non‐interventional, post‐authorization safety study MD Tarantino, B Hardesty, A Metjian, TL Ortel, J Chen, K Badejo, A Ma, ... Haemophilia 29 (5), 1259-1268, 2023 | | 2023 |
